Head and neck cancer is the seventh most common type of cancer worldwide and comprise
of a diverse group of tumours affecting the upper aerodigestive tract. Although many different …

Most head and neck cancers are derived from the mucosal epithelium in the oral cavity,
pharynx and larynx and are known collectively as head and neck squamous cell carcinoma …

Abstract Background and purpose The Meta-Analysis of Chemotherapy in squamous cell
Head and Neck Cancer (MACH-NC) demonstrated that concomitant chemotherapy (CT) …

To promote the clinical theranostic performances of platinum‐based anticancer drugs,
imaging capability is urgently desired, and their chemotherapeutic efficacy needs to be …

Most patients diagnosed with head and neck squamous cell carcinoma (HNSCC) will
present with locally advanced disease, requiring multimodality therapy. While this approach …

Answer questions and earn CME/CNE Laryngeal cancer remains one of the most common
tumors of the respiratory tract. Fortunately, significant advancements have been made over …

Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck
region. The risk factors for development of cancers of the oral cavity, oropharynx …

Purpose To update the guideline recommendations on the use of larynx-preservation
strategies in the treatment of laryngeal cancer. Methods An Expert Panel updated the …

Purpose To report the long-term results of the Intergroup Radiation Therapy Oncology Group
91-11 study evaluating the contribution of chemotherapy added to radiation therapy (RT) for …

Purpose We tested the efficacy and toxicity of cisplatin plus accelerated fractionation with a
concomitant boost (AFX-C) versus standard fractionation (SFX) in locally advanced head …